VALN
Valneva SE
NASDAQ · Healthcare · Biotechnology · FR
$6.89
−2.41%Leverage
- Debt / equity
- 2.59x
- Net debt / equity
- 1.09x
- Debt / assets
- 0.54x
- Debt / EBITDA
- -2.23x
- Net debt / EBITDA
- -0.94x
Liquidity & coverage
- Current ratio
- 2.16x
- Quick ratio
- 1.69x
- Cash ratio
- 1.18x
- Interest coverage
- -2.85x
- EBITDA / interest
- -2.32x
- Working capital
- $138.9M
Cash & dividend
- FCF / debt
- -0.41x
- Cash flow / debt
- -0.40x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026